To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Dealings in securities by directors

Release Date: 20/12/2017 13:09
Code(s): ASC     PDF:  
Wrap Text
Dealings in securities by directors

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)

Dealings in securities by directors

In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by directors, is disclosed:

Directors:                            Gary Shayne and Crispian Dillon

Nature of the transaction:            Shareholders are referred to the results of the
                                      Ascendis rights offer (“Rights Offer”) announced on
                                      the stock exchange news service of the JSE Limited
                                      on 18 December 2017. The Rights Offer was
                                      underwritten by a wholly owned subsidiary of
                                      Coast2Coast Capital Proprietary Limited (“C2C”) (in
                                      which Gary Shayne holds an 85% indirect interest and
                                      Crispian Dillon holds a 15% indirect interest) and C2C
                                      took up shares in terms of its underwriting
                                      commitment.

Date of transaction:                  20 December 2017

Class of shares:                      Ordinary shares


Number of shares:                     37,340,787
Price per share:                      R20.00
Value:                                R746,815,740
Nature of transaction:                Purchase in terms of the Rights Offer

Extent of interest:                   Indirect beneficial (through a wholly owned subsidiary
                                      of C2C, in which Gary Shayne has a 85% indirect
                                      beneficial interest and Crispian Dillon has a 15%
                                      indirect beneficial interest).

Written clearance obtained:           Clearance was obtained from the Chairman




Directors:                            Gary Shayne and Crispian Dillon

Nature of the transactions:           C2C is required to redeem four existing debentures,
                                      entered into on 20 July 2016, 25 June 2014, 26
                                      November 2014 and 26 November 2014 respectively,
                                      and each issued by an indirect subsidiary of C2C, by
                                      way of a settlement of Ascendis shares. The Ascendis
                                      shares are thus transferred to effect the redemption of
                                      the debentures, at a price per share determined using
                                      the pre-agreed pricing mechanism for each
                                      debenture.
Date of transactions:            20 December 2017

Class of shares:                 Ordinary shares


Number of shares:                6,983,406
Price per share:                 R26.10
Value:                           R182,266,896.60
Nature of transactions:          Sale, off market

Number of shares:                6,834,332
Price per share:                 R20.48
Value:                           R139,967,119.36
Nature of transactions:          Sale, off market

Number of shares:                3,084,789
Price per share:                 R19.46
Value:                           R60,029,993.94
Nature of transactions:          Sale, off market

Number of shares:                919,555
Price per share:                 R21.75
Value:                           R20,000,321.25
Nature of transactions:          Sale, off market

Extent of interest:              Indirect beneficial (through C2C, in which Gary
                                 Shayne has a 85% indirect beneficial interest and
                                 Crispian Dillon has a 15% indirect beneficial interest).

Written clearance obtained:      Clearance was obtained from the Chairman



Directors:                       Gary Shayne and Crispian Dillon
Class of shares:                 Ordinary shares

Date of transaction:             18 December 2017
Number of shares:                24,000
Price per share:                 R14.22
Value:                           R341,280
Nature of transaction:           Purchase on market

Date of transaction:             19 December 2017
Number of shares:                150,000
Price per share (low):           R14.10
Price per share (high):          R15.40
Volume weighted average price:   R14.9106
Value:                           R2,236,587.41
Nature of transaction:           Purchase on market

Extent of interest:              Indirect beneficial, Coast2Coast Capital Proprietary
                                 Limited Group
Written clearance obtained:   Clearance was obtained from the Chairman




20 December 2017

Johannesburg




Sponsor

Investec Bank Limited

Date: 20/12/2017 01:09:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story